Healthcare - Biotechnology - NASDAQ - US
$ 1.43
-8.92 %
$ 39.4 M
Market Cap
-0.05
P/E
CASH FLOW STATEMENT
-128 M
OPERATING CASH FLOW
-2.1 M
INVESTING CASH FLOW
32.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Fortress Biotech, Inc.
| Net Income | -60.6 M |
| Depreciation & Amortization | 6 M |
| Capital Expenditures | -63 K |
| Stock-Based Compensation | 17 M |
| Change in Working Capital | -12.5 M |
| Others | -82.7 M |
| Free Cash Flow | -136 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||
| Net Income | (60.6) | (213.9) | (164.8) | (103.0) | (101.7) | (130.8) | (99.8) | (71.3) | (53.9) | (20.4) | (37.2) | (27.6) | (36.4) | (10.0) |
| Depreciation & Amortization | 6.0 | 9.4 | 6.8 | 5.3 | 4.7 | 2.1 | 3.4 | 1.1 | 26 K | 23 K | 17 K | 3 K | 22 K | 5 K |
| Deferred Income Tax | 0 | 0 | (38.8) | (5.2) | (18.3) | 0.3 | (8.6) | 73 K | 2.1 | (0.2) | 0 | 0 | 36.3 | 0.2 |
| Stock Based Compensation | 17.0 | 23.0 | 19.5 | 13.5 | 13.2 | 15.0 | 14.0 | 12.1 | 14.3 | 5.5 | 5.9 | 3.6 | 1.5 | 2.3 |
| Other Operating Activities | (78.1) | 2.9 | 24.4 | 10.5 | 12.0 | 8.9 | 7.8 | 10.3 | 11.9 | 0.2 | 0.5 | 1.2 | (14.2) | 1.4 |
| Change in Working Capital | (12.5) | (0.7) | 36.4 | (4.8) | (4.8) | 5.7 | (2.2) | 2.0 | 5.2 | (1.5) | 1.1 | (0.4) | 1.8 | 0.3 |
| Cash From Operations | (128.2) | (179.4) | (116.5) | (83.7) | (95.0) | (98.8) | (85.4) | (45.8) | (20.4) | (16.3) | (29.6) | (23.2) | (11.0) | (5.7) |
| INVESTING CASH FLOW | ||||||||||||||
| Capital Expenditures | 63 K | (3.1) | (16.3) | (7.2) | (9.4) | (9.4) | (5.4) | (10.5) | (12.0) | 0 | (0.2) | (0.3) | (3.8) | 13 K |
| Other Items | (2.0) | (19.9) | 56.9 | 0 | 29.5 | 28.2 | (36.2) | 4.4 | 19.9 | (23.3) | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (2.1) | (22.9) | 40.5 | (7.2) | 20.1 | 18.8 | (41.6) | (6.1) | 7.9 | (23.3) | (0.2) | (0.3) | (3.8) | 13 K |
| FINANCING CASH FLOW | ||||||||||||||
| Common Stock Repurchased | (0.4) | 0 | 0 | 70 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.3) |
| Total Debt Repaid | (36.8) | 49.2 | (9.6) | (29.7) | 15.0 | 17.3 | 37.2 | 6.1 | 10.0 | 0.4 | (1.3) | 14.2 | 0 | (0.3) |
| Dividends Paid | (8.8) | (8.8) | (8.8) | (6.8) | (2.6) | (2.3) | (0.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.0) | (4.3) | 12.2 | 38.3 | 5.2 | (2.6) | 18.4 | (3.3) | (6.9) | (14.0) | (0.8) | (2.6) | 48.7 | 19.4 |
| Cash From Financing Activities | 32.7 | 75.3 | 149.0 | 172.4 | 146.7 | 50.6 | 154.2 | 42.0 | 60.9 | (10.2) | 89.2 | 40.5 | 23.1 | 19.0 |
| CHANGE IN CASH | ||||||||||||||
| Net Change In Cash | (97.6) | (127.0) | 73.0 | 81.6 | 71.8 | (29.4) | 27.1 | (9.9) | 48.4 | (49.8) | 59.3 | 17.0 | 8.3 | 13.4 |
| FREE CASH FLOW | ||||||||||||||
| Free Cash Flow | (136.3) | (182.5) | (132.9) | (90.8) | (104.4) | (108.2) | (90.9) | (56.3) | (32.4) | (16.3) | (29.8) | (23.5) | (14.8) | (5.7) |